Supplementary Data from Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)

Authors :: H.W.M. van Laarhoven
Maarten C.C.M. Hulshof
Maarten F. Bijlsma
Nicole C.T. van Grieken
Bauke Ylstra
Tanya T.D. Soeratram
Tanja D. de Gruijl
Max Nieuwdorp
Stella Mook
Richard van Hillegersberg
Jelle P. Ruurda
Nadia Haj Mohammad
Jacques J.G.H.M. Bergman
M.P.G. Dings
Sandor Schokker
Sybren L. Meijer
R.H.A. Verhoeven
E.D. Geijsen
Suzanne S. Gisbertz
Mark I. van Berge Henegouwen
Nicolien C. de Clercq
Tom van den Ende
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Table S1. Combined positivity score (CPS) in responders and non-responders at baseline. Table S2. Immunohistochemistry markers evaluated at baseline and on-treatment.

Full Text Access

Tools